Complete Filing Data
Crinetics Pharmaceuticals, Inc. reported Stockholders Equity of $992.08 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Crinetics Pharmaceuticals, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $7.7M | $1.0M | $4.0M | $0.00 | $0.00 | $71.0K | $1.2M | $2.4M | $2.0M | $589.0K |
| Research And Development Expense | $332.1M | $240.2M | $168.5M | $130.2M | $84.3M | $57.0M | $41.5M | $24.5M | $9.2M | $5.1M |
| Net Income Loss | -$465.3M | -$298.4M | -$214.5M | -$163.9M | -$107.6M | -$73.8M | -$50.4M | -$27.1M | -$9.2M | -$6.0M |
| Operating Expenses | $339.9M | $226.6M | $172.6M | $108.8M | $75.0M | $55.0M | $31.1M | $11.2M | $6.6M | |
| General And Administrative Expense | $99.7M | $58.1M | $42.4M | $24.5M | $18.0M | $13.5M | $6.7M | $1.9M | $1.5M | |
| Operating Income Loss | -$516.8M | -$338.9M | -$222.6M | -$167.9M | -$107.7M | -$75.0M | -$53.8M | -$28.7M | -$9.1M | -$6.0M |
| Nonoperating Income Expense | $51.6M | $40.9M | $13.3M | $5.0M | $61.0K | $1.1M | $3.4M | $1.6M | -$30.0K | $25.0K |
| Comprehensive Income Net Of Tax | -$464.4M | -$298.4M | -$209.6M | -$167.5M | -$108.0M | -$73.9M | -$50.3M | -$27.1M | -$9.2M | -$6.0M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $1.1M | -$14.0K | $4.9M | -$3.5M | -$407.0K | -$123.0K | $87.0K | $61.0K | ||
| Other Comprehensive Income Loss Net Of Tax | $902.0K | -$14.0K | $4.9M | -$3.5M | -$407.0K | -$123.0K | $87.0K | $61.0K | ||
| Cost Of Revenue | $1.1M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $143.0K | $1.0M | $361.0K | $0.00 | $399.0K | $640.0K | $346.0K | $988.0K | $2.7M | $458.0K | $439.0K | $3.1M | $0.00 | $0.00 | $71.0K | $321.0K | $505.0K | $367.0K | $781.0K | $548.0K | $657.0K | $442.0K | $528.0K | $640.0K | $832.0K | $45.0K | ||||
| Research And Development Expense | $90.5M | $80.3M | $76.2M | $61.9M | $58.3M | $53.3M | $43.8M | $40.6M | $38.5M | $32.0M | $33.0M | $28.3M | $21.6M | $20.5M | $17.6M | $13.7M | $12.6M | $13.9M | $12.1M | $11.8M | $10.3M | $7.3M | $7.7M | $6.9M | $5.2M | $4.7M | $2.6M | $2.5M | $2.1M | $2.1M |
| Net Income Loss | -$130.1M | -$115.6M | -$96.8M | -$76.8M | -$74.1M | -$66.9M | -$57.5M | -$51.0M | -$46.0M | -$41.9M | -$42.4M | -$34.6M | -$27.9M | -$26.1M | -$22.9M | -$18.3M | -$16.5M | -$17.4M | -$14.5M | -$14.4M | -$12.4M | -$9.0M | -$8.5M | -$7.6M | -$5.6M | -$5.5M | -$2.5M | -$2.4M | -$1.6M | -$2.6M |
| Operating Expenses | $142.7M | $130.1M | $111.8M | $87.8M | $83.2M | $74.2M | $59.3M | $54.0M | $50.7M | $43.9M | $43.5M | $37.0M | $27.8M | $26.1M | $22.9M | $18.5M | $16.9M | $17.9M | $15.5M | $15.7M | $13.3M | $10.4M | $10.2M | $8.6M | $6.3M | $6.0M | $3.0M | $3.0M | $2.5M | $2.7M |
| General And Administrative Expense | $52.3M | $49.8M | $35.5M | $25.9M | $24.8M | $20.8M | $15.5M | $13.3M | $12.2M | $11.9M | $10.5M | $8.7M | $6.2M | $5.6M | $5.3M | $4.8M | $4.3M | $4.0M | $3.4M | $3.9M | $3.1M | $3.2M | $2.6M | $1.7M | $1.1M | $1.2M | $467.0K | $491.0K | $392.0K | $589.0K |
| Operating Income Loss | -$142.6M | -$129.1M | -$111.4M | -$87.8M | -$82.8M | -$73.5M | -$59.0M | -$53.0M | -$48.0M | -$43.5M | -$43.0M | -$33.8M | -$27.8M | -$26.1M | -$22.9M | -$18.5M | -$16.9M | -$17.8M | -$15.2M | -$13.3M | -$10.0M | -$8.1M | -$5.7M | -$5.5M | -$2.4M | -$1.6M | ||||
| Nonoperating Income Expense | $12.5M | $13.5M | $14.6M | $11.0M | $8.7M | $7.1M | $2.5M | $2.0M | $2.0M | $1.5M | $670.0K | $210.0K | -$44.0K | -$6.0K | $17.0K | $131.0K | $438.0K | $422.0K | $799.0K | $918.0K | $1.0M | $482.0K | $115.0K | $62.0K | -$8.0K | -$5.0K | ||||
| Comprehensive Income Net Of Tax | -$129.5M | -$116.0M | -$95.7M | -$74.6M | -$74.4M | -$67.8M | -$56.6M | -$50.2M | -$44.6M | -$43.3M | -$43.8M | -$36.4M | -$27.9M | -$26.1M | -$22.9M | -$18.4M | -$16.5M | -$17.3M | -$14.5M | -$12.3M | -$8.9M | -$7.6M | -$5.6M | -$5.5M | ||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $594.0K | -$347.0K | $1.0M | $2.2M | -$340.0K | -$827.0K | $840.0K | $809.0K | $1.4M | -$1.4M | -$1.4M | -$1.8M | -$22.0K | -$9.0K | -$6.0K | -$83.0K | -$40.0K | $19.0K | -$36.0K | $89.0K | $84.0K | |||||||||
| Other Comprehensive Income Loss Net Of Tax | $573.0K | -$381.0K | $1.0M | $2.2M | -$340.0K | -$827.0K | $840.0K | $809.0K | $1.4M | $1.4M | -$1.4M | $1.8M | $22.0K | $9.0K | -$6.0K | -$83.0K | -$40.0K | $19.0K | -$36.0K | $89.0K | $84.0K | |||||||||
| Cost Of Revenue |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $992.1M | $1.32B | $539.1M | $316.3M | $331.9M | $168.9M | $117.1M | $160.2M | -$15.0M | -$6.2M | -$463.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $102.3M | $265.8M | $56.2M | $34.0M | $201.2M | $93.6M | $40.8M | $45.5M | $14.2M | $12.2M | $17.9M |
| Cash And Cash Equivalents At Carrying Value | $101.5M | $264.5M | $54.9M | $32.7M | $200.7M | $93.1M | $40.3M | $45.0M | $14.2M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $209.6M | $22.2M | -$167.2M | $107.6M | $52.8M | -$4.6M | $31.3M | $2.0M | -$5.7M | ||
| Property Plant And Equipment Net | $14.3M | $12.1M | $10.9M | $3.5M | $2.8M | $3.2M | $3.9M | $4.2M | $400.0K | ||
| Retained Earnings Accumulated Deficit | -$1.42B | -$952.1M | -$653.7M | -$439.2M | -$275.3M | -$167.6M | -$93.8M | -$43.4M | -$16.3M | ||
| Prepaid Expense And Other Assets Current | $17.8M | $20.8M | $15.6M | $10.8M | $11.0M | $6.6M | $4.9M | $2.8M | $973.0K | ||
| Liabilities Current | $85.1M | $59.7M | $43.9M | $27.7M | $16.0M | $10.5M | $8.3M | $7.9M | $897.0K | ||
| Liabilities And Stockholders Equity | $1.13B | $1.43B | $635.4M | $352.2M | $351.0M | $183.4M | $130.4M | $171.4M | $15.6M | ||
| Liabilities | $134.2M | $109.8M | $96.2M | $35.8M | $19.1M | $14.5M | $13.2M | $11.2M | $920.0K | ||
| Assets Current | $1.05B | $1.38B | $574.2M | $345.2M | $344.7M | $177.5M | $123.3M | $166.7M | $15.2M | ||
| Assets | $1.13B | $1.43B | $635.4M | $352.2M | $351.0M | $183.4M | $130.4M | $171.4M | $15.6M | ||
| Restricted Cash Noncurrent | $800.0K | $800.0K | $1.3M | $1.3M | $500.0K | $500.0K | $500.0K | $500.0K | |||
| Accretion Amortization Of Discounts And Premiums Investments | $15.4M | $14.9M | $6.3M | -$34.0K | -$422.0K | $227.0K | $1.2M | $433.0K | |||
| Vesting Of Shares Of Common Stock Value Subject To Repurchase | 2.0K | 21.0K | 26.0K | 94.0K | 21.0K | 2.0K | 8.0K | ||||
| Short Term Investments | $926.4M | $1.09B | $503.7M | $301.8M | $133.0M | $77.8M | $78.1M | $118.9M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $1.9M | $963.0K | $977.0K | -$3.9M | -$382.0K | $25.0K | $148.0K | $61.0K | |||
| Common Stocks Including Additional Paid In Capital | $2.41B | $2.28B | $1.19B | $759.4M | $607.6M | $336.5M | $210.8M | $203.5M | |||
| Change In Unvested Stock Liability | $0.00 | $0.00 | $2.0K | $21.0K | $26.0K | $94.0K | $21.0K | $2.0K | $8.0K | ||
| Operating Lease Right Of Use Asset | $40.5M | $43.5M | $46.5M | $1.5M | $1.9M | $2.2M | $2.5M | ||||
| Operating Lease Liability Noncurrent | $42.1M | $44.6M | $47.6M | $2.0M | $3.1M | $4.0M | $4.8M | ||||
| Non Cash Lease Expense | $3.0M | $1.2M | $406.0K | $340.0K | $278.0K | $226.0K | |||||
| Restricted Cash | $800.0K | $1.3M | $1.3M | $0.00 | $500.0K | $500.0K | $500.0K | $500.0K | |||
| Accrued Compensation And Related Expense | $35.6M | $28.9M | $14.5M | $9.1M | $6.6M | $4.1M | $2.1M | $2.3M | |||
| Accounts Payable And Accrued Liabilities Current | $41.8M | $21.5M | $23.2M | $15.4M | $8.5M | $5.6M | $5.5M | $5.3M | |||
| Equity Method Investment Realized Gain Loss On Disposal | $0.00 | -$470.0K | -$5.2M | -$1.0M | $0.00 | $0.00 | |||||
| Loss Before Equity Method Investment | $297.9M | $209.3M | $162.9M | -$107.6M | -$73.8M | ||||||
| Deferred Compensation Liability Classified Noncurrent | $0.00 | $2.0K | $23.0K | $49.0K | $202.0K | $3.0K | |||||
| Other Assets Noncurrent | $2.0M | $37.0K | $0.00 | $40.0K | $82.0K | $33.0K | |||||
| Transaction Cost On Issuance Of Common Stock | $49.4M | $22.7M | $7.8M | $13.0M | $7.5M | ||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $1.07B | $1.17B | $1.25B | $833.0M | $830.8M | $874.9M | $547.7M | $254.1M | $280.3M | $351.4M | $386.2M | $303.0M | $193.6M | $201.4M | $149.5M | $187.2M | $202.8M | $108.4M | $129.5M | $142.1M | $152.4M | $167.5M | -$25.2M | -$20.0M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $112.2M | $55.0M | $95.9M | $318.6M | $303.5M | $397.2M | $144.1M | $40.9M | $42.5M | $32.2M | $62.8M | $146.0M | $162.0M | $179.3M | $106.1M | $118.3M | $161.3M | $51.4M | $67.1M | $60.2M | $63.3M | $170.2M | $68.9M | $74.2M | $9.9M | $12.3M | |
| Cash And Cash Equivalents At Carrying Value | $110.9M | $53.7M | $94.6M | $317.3M | $302.2M | $395.9M | $142.8M | $39.6M | $41.2M | $30.9M | $62.3M | $145.5M | $161.5M | $178.8M | $105.6M | $117.8M | $160.8M | $50.9M | $66.6M | $59.7M | $62.8M | $169.7M | $68.4M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$170.0M | $341.0M | $8.5M | -$55.1M | $12.5M | $10.6M | $17.9M | $60.0M | |||||||||||||||||||
| Property Plant And Equipment Net | $14.4M | $14.7M | $12.6M | $11.7M | $12.2M | $11.9M | $9.8M | $3.2M | $3.3M | $3.6M | $3.2M | $2.7M | $2.9M | $3.0M | $3.0M | $3.4M | $3.6M | $3.8M | $4.0M | $4.3M | $4.5M | $4.4M | $1.8M | ||||
| Retained Earnings Accumulated Deficit | -$1.29B | -$1.16B | -$1.05B | -$871.5M | -$794.7M | -$720.6M | -$593.6M | -$536.1M | -$485.2M | -$394.2M | -$352.3M | -$309.9M | -$244.5M | -$216.6M | -$190.5M | -$146.0M | -$127.7M | -$111.2M | -$79.3M | -$64.8M | -$52.4M | -$34.9M | -$27.3M | ||||
| Prepaid Expense And Other Assets Current | $28.5M | $20.4M | $16.4M | $14.9M | $11.8M | $16.3M | $21.1M | $20.3M | $9.3M | $10.0M | $7.8M | $8.5M | $10.6M | $7.6M | $7.1M | $7.3M | $5.4M | $4.4M | $3.7M | $2.8M | $1.9M | $1.4M | $1.5M | ||||
| Liabilities Current | $74.2M | $68.4M | $57.3M | $53.6M | $54.4M | $51.8M | $40.5M | $32.6M | $26.3M | $24.6M | $26.1M | $20.3M | $12.4M | $11.9M | $10.3M | $8.8M | $9.9M | $10.8M | $7.9M | $7.8M | $8.8M | $5.5M | $5.6M | ||||
| Liabilities And Stockholders Equity | $1.20B | $1.29B | $1.36B | $937.4M | $935.5M | $978.2M | $641.5M | $293.3M | $314.0M | $384.9M | $421.7M | $333.3M | $209.4M | $216.9M | $163.6M | $200.3M | $217.1M | $123.9M | $142.5M | $155.1M | $166.8M | $176.7M | $74.7M | ||||
| Liabilities | $123.9M | $118.0M | $107.3M | $104.4M | $104.8M | $103.2M | $93.8M | $39.1M | $33.7M | $33.5M | $35.6M | $30.2M | $15.8M | $15.5M | $14.1M | $13.1M | $14.3M | $15.4M | $13.0M | $13.0M | $14.4M | $9.2M | $6.9M | ||||
| Assets Current | $1.12B | $1.22B | $1.29B | $877.6M | $874.8M | $917.2M | $575.8M | $284.8M | $305.4M | $378.3M | $416.3M | $328.2M | $204.0M | $211.4M | $157.8M | $194.1M | $210.6M | $117.2M | $135.4M | $147.8M | $159.1M | $171.0M | $69.9M | ||||
| Assets | $1.20B | $1.29B | $1.36B | $937.4M | $935.5M | $978.2M | $641.5M | $293.3M | $314.0M | $384.9M | $421.7M | $333.3M | $209.4M | $216.9M | $163.6M | $200.3M | $217.1M | $123.9M | $142.5M | $155.1M | $166.8M | $176.7M | $74.7M | ||||
| Restricted Cash Noncurrent | $800.0K | $800.0K | $800.0K | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | ||||
| Accretion Amortization Of Discounts And Premiums Investments | $4.4M | $3.8M | $530.0K | -$322.0K | -$83.0K | $180.0K | $400.0K | ||||||||||||||||||||
| Vesting Of Shares Of Common Stock Value Subject To Repurchase | 2.0K | 5.0K | 6.0K | 5.0K | 5.0K | 5.0K | 10.0K | 12.0K | 18.0K | 53.0K | 7.0K | 5.0K | 3.0K | ||||||||||||||
| Short Term Investments | $981.4M | $1.14B | $1.18B | $545.4M | $560.8M | $505.0M | $411.9M | $225.0M | $254.9M | $337.5M | $346.2M | $174.2M | $31.8M | $25.0M | $45.1M | $69.0M | $44.4M | $61.9M | $65.1M | $85.3M | $94.4M | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $2.2M | $1.6M | $2.0M | $2.0M | -$190.0K | $150.0K | -$865.0K | -$1.7M | -$2.5M | -$5.0M | -$3.6M | -$2.2M | -$12.0K | $10.0K | $19.0K | $44.0K | $127.0K | $167.0K | $198.0K | $234.0K | $145.0K | ||||||
| Common Stocks Including Additional Paid In Capital | $2.36B | $2.33B | $2.30B | $1.70B | $1.63B | $1.60B | $1.14B | $792.0M | $768.0M | $750.6M | $742.0M | $615.1M | $438.1M | $418.0M | $340.0M | $333.2M | $330.3M | $219.4M | $208.6M | $206.7M | $204.6M | ||||||
| Change In Unvested Stock Liability | $0.00 | $2.0K | $5.0K | $10.0K | $53.0K | -$3.0K | |||||||||||||||||||||
| Operating Lease Right Of Use Asset | $41.1M | $41.9M | $42.7M | $44.3M | $45.0M | $45.8M | $48.0M | $1.3M | $1.4M | $1.6M | $1.7M | $1.8M | $2.0M | $2.1M | $2.2M | $2.3M | $2.4M | $2.4M | $2.6M | $2.6M | $2.7M | ||||||
| Operating Lease Liability Noncurrent | $42.7M | $43.3M | $43.9M | $45.1M | $45.9M | $46.7M | $48.2M | $1.5M | $1.7M | $2.3M | $2.6M | $2.8M | $3.3M | $3.6M | $3.8M | $4.2M | $4.4M | $4.6M | $5.0M | $5.2M | $5.4M | ||||||
| Non Cash Lease Expense | $813.0K | $789.0K | $115.0K | $95.0K | $80.0K | $65.0K | $53.0K | ||||||||||||||||||||
| Restricted Cash | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | ||||||||
| Accrued Compensation And Related Expense | $32.4M | $21.8M | $16.6M | $26.2M | $20.4M | $14.8M | $12.9M | $8.6M | $6.8M | $7.7M | $5.4M | $4.5M | $5.4M | $3.9M | $3.2M | $3.3M | $2.3M | $1.7M | |||||||||
| Accounts Payable And Accrued Liabilities Current | $33.7M | $38.1M | $31.6M | $18.3M | $24.0M | $28.7M | $21.9M | $20.8M | $16.3M | $13.5M | $17.1M | $12.1M | $6.2M | $7.1M | $6.2M | $4.7M | $6.8M | $8.3M | |||||||||
| Equity Method Investment Realized Gain Loss On Disposal | $0.00 | $0.00 | $0.00 | $0.00 | -$470.0K | -$997.0K | $0.00 | $0.00 | $0.00 | $0.00 | -$1.0M | $0.00 | $0.00 | $0.00 | |||||||||||||
| Loss Before Equity Method Investment | $115.6M | $96.8M | $76.8M | $74.1M | $66.5M | $56.5M | $51.0M | $46.0M | $41.9M | $42.4M | $33.6M | $27.9M | $26.1M | $22.9M | |||||||||||||
| Deferred Compensation Liability Classified Noncurrent | $0.00 | $0.00 | $7.0K | $12.0K | $18.0K | $28.0K | $34.0K | $39.0K | $60.0K | $72.0K | $150.0K | $209.0K | $217.0K | ||||||||||||||
| Other Assets Noncurrent | $14.2M | $2.8M | $2.5M | $2.2M | $2.0M | $2.0M | $2.0M | $2.0M | $789.0K | $2.5M | |||||||||||||||||
| Transaction Cost On Issuance Of Common Stock | $1.5M | $15.8M | $21.5M | $350.0K | $7.8M | $24.0M | $2.4M | ||||||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Issuance Of Common Stock | $0.00 | $985.0M | $369.6M | $117.2M | $249.5M | $114.3M | $106.5M | |||
| Share Based Compensation | $91.0M | $69.4M | $40.9M | $28.3M | $17.4M | $10.4M | $6.3M | $2.3M | $271.0K | $270.0K |
| Payments To Acquire Property Plant And Equipment | $5.8M | $3.8M | $4.7M | $1.7M | $436.0K | $186.0K | $492.0K | $1.1M | $304.0K | $190.0K |
| Net Cash Provided By Used In Operating Activities | -$377.9M | -$230.2M | -$168.6M | -$115.2M | -$88.6M | -$62.0M | -$46.4M | -$19.5M | -$9.5M | -$5.5M |
| Net Cash Provided By Used In Investing Activities | $173.9M | -$574.8M | -$200.4M | -$174.0M | -$56.5M | $217.0K | $41.7M | -$119.5M | -$304.0K | -$190.0K |
| Net Cash Provided By Used In Financing Activities | $40.6M | $1.01B | $391.2M | $122.0M | $252.7M | $114.6M | $67.0K | $170.2M | $11.8M | -$53.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $16.5M | $6.0M | $4.5M | -$215.0K | $4.4M | $1.6M | $2.2M | $1.8M | $783.0K | $116.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $29.0M | $13.3M | $12.4M | $11.0M | $6.3M | $2.7M | $696.0K | $7.4M | $47.0K | $300.0K |
| Proceeds From Stock Options Exercised | $40.4M | $19.9M | $4.7M | $3.1M | $288.0K | $126.0K | $451.0K | $66.0K | ||
| Payments To Acquire Available For Sale Securities Debt | $1.00B | $1.15B | $527.9M | $329.8M | $125.4M | $135.6M | $108.1M | $118.4M | ||
| Proceeds From Sale And Maturity Of Available For Sale Securities | $1.18B | $575.8M | $337.1M | $157.5M | $69.4M | $136.0M | $150.3M | |||
| Increase Decrease In Operating Lease Liabilities | -$6.0K | -$546.0K | -$938.0K | -$836.0K | -$724.0K | -$608.0K | ||||
| Payments Of Stock Issuance Costs | $0.00 | $15.0M | $541.0K | $7.8M | $13.0M | $7.5M | ||||
| Increase Decrease In Commodity Contract Assets And Liabilities | -$74.0K | $1.5M | -$8.3M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q1 2024 | Q1 2023 | Q3 2022 | Q1 2022 | Q1 2021 | Q1 2020 | Q3 2019 | Q1 2019 | Q2 2018 | Q1 2018 | Q2 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Issuance Of Common Stock | $0.00 | $32.1K | $383.2M | $0.00 | $150.0M | $6.4M | $150.0M | ||||||
| Share Based Compensation | $20.5M | $13.5M | $8.1M | $5.8M | $3.4M | $2.1M | $1.0M | $271.0K | $426.0K | $73.0K | |||
| Payments To Acquire Property Plant And Equipment | $1.2M | $1.3M | $16.0K | $87.0K | $116.0K | $60.0K | $408.0K | $57.0K | |||||
| Net Cash Provided By Used In Operating Activities | -$88.5M | -$52.9M | -$40.7M | -$13.5M | -$20.1M | -$12.2M | -$6.8M | -$3.4M | |||||
| Net Cash Provided By Used In Investing Activities | -$86.0M | $309.0K | $48.8M | -$43.4M | $32.5M | $16.3M | $24.6M | -$57.0K | |||||
| Net Cash Provided By Used In Financing Activities | $4.4M | $393.6M | $484.0K | $1.8M | $57.0K | $6.5M | $20.0K | $63.5M | |||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $6.9M | -$212.0K | -$1.5M | -$2.5M | $487.0K | -$663.0K | -$905.0K | $290.0K | |||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$1.4M | $1.3M | -$1.3M | $1.5M | -$271.0K | $2.4M | $583.0K | $1.9M | |||||
| Proceeds From Stock Options Exercised | $4.4M | $10.4M | $484.0K | $1.8M | $57.0K | $55.0K | $20.0K | $253.0K | |||||
| Payments To Acquire Available For Sale Securities Debt | $391.2M | $99.7M | $22.7M | $55.0M | $2.5M | $22.9M | $31.6M | ||||||
| Proceeds From Sale And Maturity Of Available For Sale Securities | $306.5M | $101.4M | $71.4M | $11.7M | $35.2M | $39.3M | $56.6M | ||||||
| Increase Decrease In Operating Lease Liabilities | -$903.0K | $776.0K | -$253.0K | -$226.0K | -$201.0K | -$172.0K | -$115.0K | ||||||
| Payments Of Stock Issuance Costs | $0.00 | $17.3M | $15.8M | $134.0K | |||||||||
| Increase Decrease In Commodity Contract Assets And Liabilities | $361.0K | -$398.0K | $605.0K | -$9.9M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$4.95 | -$3.69 | -$3.69 | -$3.15 | -$2.80 | -$2.42 | -$2.09 | -$2.23 | -$6.68 | -$5.96 |
| Common Stock Shares Outstanding | 95.6M | 92.9M | 68.2M | 53.9M | 47.6M | 33.0M | 24.3M | 24.1K | 1.5M | |
| Common Stock Shares Issued | 95.6M | 92.9M | 68.2M | 53.9M | 47.6M | 33.0M | 24.3M | 24.2K | 2.1M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0K | 50.5M | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0K | 10.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 38.4M | 30.4M | 24.2M | 12.1M | 1.4M | 1.0M | ||||
| Weighted Average Number Of Shares Outstanding Basic | 94.1M | 80.8M | 58.1M | 52.0M | 38.4M | 30.4M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 94.1M | 80.8M | 58.1M | 52.0M | 38.4M | 30.4M | ||||
| Earnings Per Share Basic | $-4.95 | $-3.69 | $-3.69 | $-3.15 | $-2.80 | $-2.42 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.38 | -$1.23 | -$1.04 | -$0.96 | -$0.94 | -$0.93 | -$1.01 | -$0.94 | -$0.85 | -$0.78 | -$0.81 | -$0.73 | -$0.73 | -$0.70 | -$0.69 | -$0.56 | -$0.53 | -$0.71 | -$0.60 | -$0.60 | -$0.51 | -$0.37 | -$0.35 | -$0.38 | -$2.41 | -$2.92 | -$1.68 | -$1.67 | -$1.22 | -$2.18 |
| Common Stock Shares Outstanding | 94.5M | 94.1M | 93.5M | 80.8M | 79.3M | 78.5M | 66.7M | 54.7M | 54.0M | 53.8M | 53.7M | 47.8M | 38.6M | 37.7M | 33.0M | 32.9M | 32.9M | 24.6M | 24.2M | 24.2M | 24.1M | 24.0M | 2.3M | |||||||
| Common Stock Shares Issued | 94.5M | 94.1M | 93.5M | 80.8M | 79.3M | 78.5M | 66.7M | 54.7M | 54.0M | 53.8M | 53.7M | 47.8M | 38.6M | 37.7M | 33.0M | 32.9M | 32.9M | 24.6M | 24.3M | 24.2M | 24.2M | 24.2M | 2.5M | |||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 65.0M | |||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 47.7M | 38.3M | 37.1M | 33.0M | 32.9M | 31.4M | 24.5M | 24.2M | 24.2M | 24.1M | 20.0M | 2.3M | 1.9M | 1.4M | 1.3M | |||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 94.2M | 93.8M | 93.1M | 80.1M | 79.0M | 72.3M | 56.8M | 54.3M | 53.9M | 53.8M | 52.5M | 47.7M | 38.3M | 37.1M | ||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 94.2M | 93.8M | 93.1M | 80.1M | 79.0M | 72.3M | 56.8M | 54.3M | 53.9M | 53.8M | 52.5M | 47.7M | 38.3M | 37.1M | ||||||||||||||||
| Earnings Per Share Basic | $-1.38 | $-1.23 | $-1.04 | $-0.96 | $-0.94 | $-0.93 | $-1.01 | $-0.94 | $-0.85 | $-0.78 | $-0.81 | $-0.73 | $-0.73 | $-0.70 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $52.0M | $41.4M | $13.4M | $4.3M | $157.0K | $991.0K | $3.5M | $1.7M | $26.0K | $37.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $91.0M | $69.4M | $40.9M | $28.3M | $17.4M | $10.4M | $6.3M | $2.3M | $271.0K | $270.0K |
| Stock Issued During Period Value Stock Options Exercised | $35.4M | $40.5M | $20.1M | $4.7M | $3.1M | $288.0K | $126.0K | $231.0K | $66.0K | |
| Other Income Expense | -$519.0K | -$159.0K | $57.0K | -$96.0K | $150.0K | -$50.0K | -$153.0K | |||
| Depreciation And Amortization | $3.9M | $2.8M | $1.1M | $983.0K | $922.0K | $948.0K | $887.0K | $471.0K | $128.0K | $92.0K |
| Stock Issued During Period Value Employee Stock Purchase Plan | $5.2M | $4.2M | $2.3M | $1.6M | $1.0M | $691.0K | $735.0K | $282.0K | ||
| Capital Expenditures Incurred But Not Yet Paid | $389.0K | $180.0K | $872.0K | $0.00 | $130.0K | $6.0K | $112.0K | $42.0K | ||
| Stock Issued During Period Value New Issues | $970.0M | $369.1M | $117.2M | $249.5M | $114.3M | $106.5M | ||||
| Purchase Of Shares Pursuant To Employee Stock Purchase Plan | 4.2M | 2.3M | 1.6M | 1.0M | 691.0K | 735.0K | 282.0K | |||
| Other Noncash Income Expense | $0.00 | $0.00 | $1.0K | $17.0K | $4.0K | $433.0K | ||||
| Stock Issued During Period Shares Stock Options Exercised | 2.0M | 2.3M | 1.3M | 524.8M | 364.3M | 170.7K | 90.3K | 479.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $12.5M | $13.5M | $14.8M | $11.0M | $8.7M | $7.3M | $2.6M | $2.1M | $2.0M | $1.5M | $720.0K | $193.0K | $24.0K | $23.0K | $30.0K | $122.0K | $260.0K | $556.0K | $835.0K | $960.0K | $1.0M | $534.0K | $151.0K | $64.0K | $6.0K | $7.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $22.7M | $26.1M | $20.5M | $18.1M | $18.9M | $13.5M | $11.0M | $10.2M | $8.1M | $7.4M | $7.1M | $5.8M | $4.6M | $4.2M | $3.4M | $2.8M | $2.5M | $2.1M | $1.9M | $1.6M | $1.0M | $775.0K | $271.0K | $426.0K | ||
| Stock Issued During Period Value Stock Options Exercised | $7.5M | $4.5M | $4.5M | $10.4M | $9.2M | $11.2M | $10.7M | $1.3M | $484.0K | $1.1M | $1.7M | $1.8M | $487.0K | $745.0K | $57.0K | $64.0K | $72.0K | $55.0K | $22.0K | $67.0K | $20.0K | $59.0K | $91.0K | $81.0K | ||
| Other Income Expense | $20.0K | -$203.0K | -$37.0K | -$13.0K | -$251.0K | -$53.0K | -$91.0K | -$55.0K | $29.0K | -$81.0K | $17.0K | -$68.0K | -$29.0K | -$13.0K | $9.0K | $178.0K | -$134.0K | -$36.0K | -$42.0K | $18.0K | -$52.0K | -$36.0K | -$2.0K | -$12.0K | -$9.0K | |
| Depreciation And Amortization | $925.0K | $474.0K | $283.0K | $240.0K | $224.0K | $235.0K | $200.0K | $48.0K | ||||||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $2.9M | $2.0M | $1.1M | $813.0K | $15.0M | $522.0K | $407.0K | $6.4M | $379.0K | |||||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $264.0K | $168.0K | $33.0K | $0.00 | $21.0K | $27.0K | $67.0K | |||||||||||||||||||
| Stock Issued During Period Value New Issues | $48.3M | $378.9M | $328.5M | $11.3M | $117.2M | $15.0M | $72.6M | $107.9M | $6.4M | |||||||||||||||||
| Purchase Of Shares Pursuant To Employee Stock Purchase Plan | ||||||||||||||||||||||||||
| Other Noncash Income Expense | $19.0K | -$3.0K | -$2.0K | |||||||||||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 215.4K | 605.1K | 31.8K | 203.0K | 13.00 | 42.00 | 21.2K |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.